Fusion Energy Capital

Pushing fusion energy forward, while reducing the risk of investing

[Fusion Energy Capital @FusionEnergyCap]

Partner Wanted:

We run a venture firm focused on fusion energy & directly enabling technologies. We've made several early investments and have strong connections across the industry.

Now, we're ready to scale—but to do that, we need to expand our LP base.
1/

[SHINE Technologies @shinefusion]

On our road to terbium production, we've unlocked an exciting achievement: gadolinium enrichment. We're not in commercial production yet, but our capability is proven.

Read more about how we did it: https://t.co/2qcjiJfOk3

[SHINE Technologies @shinefusion]

Commercializing fusion doesn't have to start with energy, as our founder and CEO Greg explains on a recent podcast. We're commercializing fusion technology with neutron imaging and cancer medicine and building toward nuclear waste recycling.
Podcast here:
https://t.co/Mz9xGBUv38

[Fusion Energy Capital @FusionEnergyCap]

Good article highlighting one of our portfolio companies: @shinefusion.

[Heatmap News @heatmap_news]

A fusion company that's making money already? Yes, it's true!

Here's @katie_brigham on Shine Technologies, which has found some lucrative uses for its tech as it works toward achieving net energy generation:

https://t.co/zMISeHmz17

[Fusion Energy Capital @FusionEnergyCap]

If you’re excited about the future of fusion, believe in its potential, and know how to connect capital with conviction—let’s talk.

DMs are open. Referrals welcome.
5/5

[Fusion Energy Capital @FusionEnergyCap]

Partner Wanted:

We run a venture firm focused on fusion energy & directly enabling technologies. We've made several early investments and have strong connections across the industry.

Now, we're ready to scale—but to do that, we need to expand our LP base.
1/

[Fusion Energy Capital @FusionEnergyCap]

We’re looking for a partner who has experience raising capital for venture funds and can help us build long term LP relationships.

We're open on structure, this could be a carry-based role or a full partnership, depending on fit.
4/

[Fusion Energy Capital @FusionEnergyCap]

Excellent news!

[SHINE Technologies @shinefusion]

We've partnered with Modawina Medical Company to bring Ilumira (n.c.a. Lu-177) to the UAE. This expands our global footprint in medical isotopes and ensures more patients can access these cancer therapies. We're taking another step forward in making precision medicine global!

[SHINE Technologies @shinefusion]

We’ve signed a definitive agreement to acquire Lantheus’ SPECT division, a leader in nuclear diagnostics. This means broader access to life-saving diagnostics, faster launches of more isotopes from Chrysalis, and a world-class team joining us.

PR here: https://t.co/s0citOQEtQ

[Fusion Energy Capital @FusionEnergyCap]

...
The partnership, formalized through a Memorandum of Understanding (MOU), will explore and develop pathways for SCOA to promote and distribute SHINE's innovative products and services throughout Japan and other Asian markets."

[Fusion Energy Capital @FusionEnergyCap]

"SHINE Technologies, a next-generation fusion company, today announced a strategic partnership with Sumitomo Corporation of Americas (SCOA), a leading global trading and investment company.
...

https://t.co/6317IWz7XZ

[SHINE Technologies @shinefusion]

We're proud to put Janesville, Wisconsin on the map for nuclear fusion!
Great article spotlighting numerous Wisconsin fusion companies and partners Realta, TypeOne and Wisconsin Alumni Research Foundation (WARF)

https://t.co/64hH69UpR1

[Fusion is the Future @is_fusion]

Here’s an hour long Fusion Fireplace video to help make the Season bright.

Chestnuts roasting on a plasma fire…

https://t.co/acykZdLUoz

[Fusion Energy Capital @FusionEnergyCap]

This is wonderful to see 👏

[SHINE Technologies @shinefusion]

Curious how modern cancer treatments target tumors while sparing healthy tissue? We explain the science behind non-carrier-added lutetium-177 (n.c.a. Lu-177) and why domestic production is key to making this life-saving therapy more accessible than ever.
https://t.co/4LmGyg7gTP

[SHINE Technologies @shinefusion]

Our Business Development Manager of Isotopes, David Bailey will discuss “A Supply Chain Lens: Exploring Isotope Viability from Production Challenges to Market Potential” on a panel, this week Thursday at TRP EU. Tune in on the conversation if you are attending the conference.

[Fusion Energy Capital @FusionEnergyCap]

And have a look at this tour through their facility.

https://t.co/EqqRHB28vg

[SHINE Technologies @shinefusion]

Take a look inside Chrysalis, our state-of-the-art production facility under construction in Janesville, WI. As our founder and CEO @GregPiefer explains, it will be "the first major beneficial use of fusion to benefit humanity on a massive scale." https://t.co/Phl9rX953O

[Fusion Energy Capital @FusionEnergyCap]

So exciting to see this!

[SHINE Technologies @shinefusion]

We're seeing exciting progress at Chrysalis, soon to be the world's largest medical isotope production and irradiation facility. Every milestone brings us closer to producing millions of doses of life-saving cancer medicines right here in Wisconsin.

[SHINE Technologies @shinefusion]

When it comes to supporting the world’s need for nuclear medicine, one product shines bright. Ilumira, our n.c.a. Lu-177, offers unmatched radionuclidic purity and immediate worldwide shipping to bring life-saving medicine within reach.
https://t.co/19sA6eaIzZ

[SHINE Technologies @shinefusion]

Medical isotopes such as lutetium-177 can save lives. But supply shortages are a critical challenge in healthcare. Our approach creates a cleaner, safer, more reliable supply of critical diagnostic and therapeutic isotopes.
https://t.co/KJgFHXVp43